Growth Metrics

BioNTech SE (BNTX) Gross Margin (2018 - 2025)

BioNTech SE (BNTX) posted Gross Margin of 63.27% for Q4 2025, down 29.89% on a QoQ basis from 90.24% in Q3 2025, and down 1627.0% year-over-year from 4.14% in Q4 2024.

BioNTech SE (BNTX) has 8 years of Gross Margin data on file, last reported at 63.27% in Q4 2025.

  • In Q4 2025, Gross Margin fell 1627.0% year-over-year to 63.27%; the TTM figure through Dec 2025 stood at 77.83% (down 183.0% YoY), while the FY2025 annual figure was 77.64%, up 48830.0% from the prior year.
  • Gross Margin retreated to 63.27% in Q4 2025, from 90.24% in the prior quarter.
  • Across five years, Gross Margin topped out at 100.0% in Q4 2021 and bottomed at 82.32% in Q2 2024.
  • A 5-year average of 69.7% and a median of 80.81% in 2022 frame the typical range for Gross Margin.
  • Annual changes were most pronounced in 2024 — Gross Margin slumped 8518 bps — and 2025, when it jumped 15302 bps.
  • Year by year, Gross Margin stood at 100.0% in 2021, then dropped by 4 bps to 95.71% in 2022, then dropped by 8 bps to 87.89% in 2023, then decreased by 10 bps to 79.54% in 2024, then fell by 20 bps to 63.27% in 2025.
  • The last three Gross Margin figures came in at 63.27% (Q4 2025), 90.24% (Q3 2025), and 70.71% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 79.04%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 86.85%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 91.79%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 82.22%
10 BioNTech SE 27.66 Bn 7.53 Bn 668.28 Mn 63.27%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 63.27%
Sep 30, 2025 90.24%
Jun 30, 2025 70.71%
Mar 31, 2025 -261.21%
Dec 31, 2024 -7,278.79%
Sep 30, 2024 85.63%
Jun 30, 2024 -82.32%
Mar 31, 2024 -542.39%
Dec 31, 2023 87.89%
Sep 30, 2023 81.93%
Jun 30, 2023 2.86%
Mar 31, 2023 92.48%
Dec 31, 2022 95.71%
Sep 30, 2022 78.25%
Jun 30, 2022 76.08%
Mar 31, 2022 79.70%
Dec 31, 2021 89.46%
Sep 30, 2021 100.00%
Jun 30, 2021 83.35%
Mar 31, 2021 88.62%
Dec 31, 2020 88.13%
Sep 30, 2020 89.80%
Jun 30, 2020 86.44%
Mar 31, 2020 78.78%
Sep 30, 2019 85.24%
Jun 30, 2019 78.71%
Mar 31, 2019 87.75%
Dec 31, 2018 92.98%
Sep 30, 2018 86.38%